Literature DB >> 25955123

PEGylated graphene oxide for tumor-targeted delivery of paclitaxel.

Hongyang Xu1, Minmin Fan, Abdelbary M A Elhissi, Zhirong Zhang, Ka-Wai Wan, Waqar Ahmed, David A Phoenix, Xun Sun.   

Abstract

AIM: The graphene oxide (GO) sheet has been considered one of the most promising carbon derivatives in the field of material science for the past few years and has shown excellent tumor-targeting ability, biocompatibility and low toxicity. We have endeavored to conjugate paclitaxel (PTX) to GO molecule and investigate its anticancer efficacy. MATERIALS &
METHODS: We conjugated the anticancer drug PTX to aminated PEG chains on GO sheets through covalent bonds to get GO-PEG-PTX complexes. The tissue distribution and anticancer efficacy of GO-PEG-PTX were then investigated using a B16 melanoma cancer-bearing C57 mice model.
RESULTS: The GO-PEG-PTX complexes exhibited excellent water solubility and biocompatibility. Compared with the traditional formulation of PTX (Taxol®), GO-PEG-PTX has shown prolonged blood circulation time as well as high tumor-targeting and -suppressing efficacy.
CONCLUSION: PEGylated graphene oxide is an excellent nanocarrier for paclitaxel for cancer targeting.

Entities:  

Keywords:  cancer therapy; drug delivery; graphene oxide; paclitaxel

Mesh:

Substances:

Year:  2015        PMID: 25955123     DOI: 10.2217/nnm.14.233

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  14 in total

Review 1.  Multifunctionalization of graphene and graphene oxide for controlled release and targeted delivery of anticancer drugs.

Authors:  Cui-Cui Liu; Jing-Jing Zhao; Rui Zhang; Hui Li; Bo Chen; Ling-Ling Zhang; Hao Yang
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  Interaction Mechanism of Doxorubicin and SWCNT: Protonation and Diameter Effects on the Drug Loading and Releasing.

Authors:  Yixuan Wang; Zhenfeng Xu
Journal:  RSC Adv       Date:  2015-12-03       Impact factor: 3.361

Review 3.  Radio-graphene in Theranostic Perspectives.

Authors:  Do Won Hwang
Journal:  Nucl Med Mol Imaging       Date:  2016-03-18

Review 4.  Applications and toxicity of graphene family nanomaterials and their composites.

Authors:  Zorawar Singh
Journal:  Nanotechnol Sci Appl       Date:  2016-03-16

5.  Doxorubicin and anti-VEGF siRNA co-delivery via nano-graphene oxide for enhanced cancer therapy in vitro and in vivo.

Authors:  Qi Sun; Xiaoli Wang; Chunying Cui; Jing Li; Yifan Wang
Journal:  Int J Nanomedicine       Date:  2018-06-27

6.  Autophagic flux induced by graphene oxide has a neuroprotective effect against human prion protein fragments.

Authors:  Jae-Kyo Jeong; You-Jin Lee; Seung Yol Jeong; Sooyeon Jeong; Geon-Woong Lee; Sang-Youel Park
Journal:  Int J Nanomedicine       Date:  2017-11-08

7.  Anti-HER2 functionalized graphene oxide as survivin-siRNA delivery carrier inhibits breast carcinoma growth in vitro and in vivo.

Authors:  Xiaoli Wang; Qi Sun; Chunying Cui; Jing Li; Yifan Wang
Journal:  Drug Des Devel Ther       Date:  2018-09-07       Impact factor: 4.162

8.  Application of luteolin nanomicelles anti-glioma effect with improvement in vitro and in vivo.

Authors:  Songping Zheng; Yongzhong Cheng; Yan Teng; Xiaoxiao Liu; Ting Yu; Yi Wang; Jiagang Liu; Yuzhu Hu; Cong Wu; Xiang Wang; Yanhui Liu; Chao You; Xiang Gao; Yuquan Wei
Journal:  Oncotarget       Date:  2017-05-19

9.  Polylactide-tethered prodrugs in polymeric nanoparticles as reliable nanomedicines for the efficient eradication of patient-derived hepatocellular carcinoma.

Authors:  Hangxiang Wang; Liqian Zhou; Ke Xie; Jiaping Wu; Penghong Song; Haiyang Xie; Lin Zhou; Jialin Liu; Xiao Xu; Youqing Shen; Shusen Zheng
Journal:  Theranostics       Date:  2018-06-24       Impact factor: 11.556

10.  Enhanced antitumor activity of bovine lactoferrin through immobilization onto functionalized nano graphene oxide: an in vitro/in vivo study.

Authors:  Azam Najmafshar; Mahboubeh Rostami; Jaleh Varshosaz; Dariush Norouzian; Seyed Ziyae Aldin Samsam Shariat
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.